The risk of cancer may be modulated by drugs with pleiotropic effects and diet has been implicated in the efficacy of treatment. The oncopreventive effects of the antidiabetic drug pioglitazone (PIO) and the anti-insomnia drug melatonin (MT), in vivo, have been proven before, but using a standard-type diet. This study evaluated the impact of a high-fat diet on their efficacy in chemically induced mammary carcinogenesis in Sprague-Dawley rats. Mammary tumours were induced by N-methyl-N-nitrosourea (50 mg/kg, intraperitoneal, on the 41st postnatal day). PIO and MT administration was initiated 11 days before the carcinogen application and lasted until the termination of the experiment at 16 weeks. PIO was administered in a diet (10% fat) at a concentration of 100 ppm and MT was administered in tap water (20 mg/l). PIO, MT and the combination did not significantly alter the basic tumour growth parameters. However, histopathology showed a decrease in the high-grade/low-grade tumour ratio, particularly in animals that received combined treatment (P<0.01). Semiquantitative immunohistochemistry indicated the proapoptotic effect of chemoprevention, particularly in the drug combination group (P<0.01), but no changes in tumour cell proliferation and angiogenesis were recorded. Results were evaluated by one-way analysis of variance or the Mann-Whitney U-test, respectively. PIO and MT, alone or in combination, administered to rats fed a high-fat diet reduced the proportion of high-grade tumours and promoted apoptosis in an in-vivo breast cancer model, although it did not suppress tumour growth. The impact of high dietary fat content on the chemopreventive efficacy of these and other substances should be considered in human studies.

Department of Animal Physiology Institute of Biology and Ecology Faculty of Science Pavol Jozef Šafárik University Košice bDepartment of Pathology St Elisabeth Oncology Institute Slovak Medical University Bratislava cDepartment of Medical Biology dDepartment of Anatomy eDepartment of Histology and Embryology Jessenius Faculty of Medicine Comenius University in Bratislava Martin Slovak Republic fInternational Clinical Research Center St Anne's University Hospital and Masaryk University Brno Czech Republic gThe Centre for Chronic Disease Prevention and Management College of Health and Biomedicine Victoria University Melbourne Victoria Australia

000      

00000naa a2200000 a 4500

001      

bmc18011342

003      

CZ-PrNML

005      

20180418101159.0

007      

ta

008      

180404s2016 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1097/CEJ.0000000000000195 $2 doi

035    __

$a (PubMed)26340057

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Bojková, Bianka $u aDepartment of Animal Physiology, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University, Košice bDepartment of Pathology, St. Elisabeth Oncology Institute, Slovak Medical University, Bratislava cDepartment of Medical Biology dDepartment of Anatomy eDepartment of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovak Republic fInternational Clinical Research Center, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic gThe Centre for Chronic Disease Prevention & Management, College of Health & Biomedicine, Victoria University, Melbourne, Victoria, Australia.

245    10

$a Role of high-fat diet on the effect of pioglitazone and melatonin in a rat model of breast cancer / $c B. Bojková, P. Orendáš, K. Kajo, P. Kubatka, D. Výbohová, S. Bálentová, P. Kružliak, A. Zulli, V. Demečková, M. Péč, M. Adamkov,

520    9_

$a The risk of cancer may be modulated by drugs with pleiotropic effects and diet has been implicated in the efficacy of treatment. The oncopreventive effects of the antidiabetic drug pioglitazone (PIO) and the anti-insomnia drug melatonin (MT), in vivo, have been proven before, but using a standard-type diet. This study evaluated the impact of a high-fat diet on their efficacy in chemically induced mammary carcinogenesis in Sprague-Dawley rats. Mammary tumours were induced by N-methyl-N-nitrosourea (50 mg/kg, intraperitoneal, on the 41st postnatal day). PIO and MT administration was initiated 11 days before the carcinogen application and lasted until the termination of the experiment at 16 weeks. PIO was administered in a diet (10% fat) at a concentration of 100 ppm and MT was administered in tap water (20 mg/l). PIO, MT and the combination did not significantly alter the basic tumour growth parameters. However, histopathology showed a decrease in the high-grade/low-grade tumour ratio, particularly in animals that received combined treatment (P<0.01). Semiquantitative immunohistochemistry indicated the proapoptotic effect of chemoprevention, particularly in the drug combination group (P<0.01), but no changes in tumour cell proliferation and angiogenesis were recorded. Results were evaluated by one-way analysis of variance or the Mann-Whitney U-test, respectively. PIO and MT, alone or in combination, administered to rats fed a high-fat diet reduced the proportion of high-grade tumours and promoted apoptosis in an in-vivo breast cancer model, although it did not suppress tumour growth. The impact of high dietary fat content on the chemopreventive efficacy of these and other substances should be considered in human studies.

650    _2

$a zvířata $7 D000818

650    _2

$a antioxidancia $x farmakologie $7 D000975

650    _2

$a karcinogeny $x toxicita $7 D002273

650    _2

$a dieta s vysokým obsahem tuků $x škodlivé účinky $7 D059305

650    _2

$a modely nemocí na zvířatech $7 D004195

650    _2

$a kombinovaná farmakoterapie $7 D004359

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a hypoglykemika $x farmakologie $7 D007004

650    _2

$a experimentální nádory mléčných žláz $x farmakoterapie $x etiologie $x patologie $7 D008325

650    _2

$a melatonin $x farmakologie $7 D008550

650    _2

$a methylnitrosomočovina $x toxicita $7 D008770

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani Sprague-Dawley $7 D017207

650    _2

$a thiazolidindiony $x farmakologie $7 D045162

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Orendáš, Peter

700    1_

$a Kajo, Karol

700    1_

$a Kubatka, Peter

700    1_

$a Výbohová, Desanka

700    1_

$a Bálentová, Soňa

700    1_

$a Kružliak, Peter

700    1_

$a Zulli, Anthony

700    1_

$a Demečková, Vlasta

700    1_

$a Péč, Martin

700    1_

$a Adamkov, Marián

773    0_

$w MED00001604 $t European journal of cancer prevention the official journal of the European Cancer Prevention Organisation (ECP) $x 1473-5709 $g Roč. 25, č. 5 (2016), s. 395-403

856    41

$u https://pubmed.ncbi.nlm.nih.gov/26340057 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20180404 $b ABA008

991    __

$a 20180418101258 $b ABA008

999    __

$a ok $b bmc $g 1288827 $s 1008154

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2016 $b 25 $c 5 $d 395-403 $i 1473-5709 $m European journal of cancer prevention $n Eur J Cancer Prev $x MED00001604

LZP    __

$a Pubmed-20180404